UK Government puts forward revised biopharma R&D tax credit cap
The UK BioIndustry Association has welcomed revised proposals to ensure genuine biotech companies are not penalised by a cap on R&D tax credits
Breaking News
Data standards: the key to making the "lab of the future" dream a reality
The lack of industry wide data standards could hold back innovation in life sciences R&D, suggest Dr Jarek Tomczak and ...
J&J selects COVID-19 vaccine candidate with support of US government
Johnson & Johnson has selected a lead COVID-19 vaccine candidate from constructs it has been working on since January ...
How digitalisation helps chemical operators become more sustainable
Sustainability is fast becoming a key discussion topic around the boardroom tables of operators working across the ...
New technology in cell and gene therapies to meet patient needs
Angela Myers, Head of Gene Editing and Novel Modalities at Merck, outlines the challenges arising with the increasing ...
Evox Therapeutics and Takeda sign multitarget rare disease collaboration
Collaboration focuses on developing novel protein replacement and mRNA therapies and explores the targeted delivery of ...
New eTheRNA led international consortium to develop COV-2 mRNA vaccineCV-19
eTheRNA launches an international consortium and starts development of cross-strain protective CoV-2 mRNA vaccine for ...
Sustainability and innovation in the complex combination therapy sector
The patient and commercial benefits of bringing new drugs to market in the shortest possible time are well recognised; ...
Positive update on the development of new XF‐platform drug formulations
Collaboration with MedPharm delivers data profiling new XF‐platform drug formulations as potential treatments for ...
e-therapeutics launches anti-viral drug discovery initiative for COVID-19
UK-based e-therapeutics discusses the moral responsibility of business and reaches out for aid with a network-driven ...
Cloud-based laboratory management solutions for increased productivity
Laboratory researchers across the globe are all challenged with similar barriers to productivity. Regardless of the ...
How AI will disrupt drug development
In the last 4–6 years, companies have been experimenting with new approaches that utilise the latest in artificial ...
Automation in the lab boosts real-time collaboration
The trend towards global collaboration in the lab is showing no sign of slowing, so companies must streamline this ...
High-throughput technologies: a paradigm shift in biopharmaceutical development
The growing demand for innovative biopharmaceutical products is putting pressure on the pharmaceutical biotechnology ...
SGS Biosafety Laboratory offers GMP compliant vaccine testing solution for coronavirus
SGS is offering testing services for new viral threats/pandemics using rapid and advanced testing platforms, such as ...
In Brief
Most Popular in Research
- How digitalisation helps chemical operators become more sustainable
- J&J selects COVID-19 vaccine candidate with support of US government
- Data standards: the key to making the "lab of the future" dream a reality
- Sustainability and innovation in the complex combination therapy sector
- Merck to provide Provantage manufacturing services to Y-mAbs
Featured Companies
Reports
